US3847924A - Certain scopolammonium compounds - Google Patents

Certain scopolammonium compounds Download PDF

Info

Publication number
US3847924A
US3847924A US00365728A US36572873A US3847924A US 3847924 A US3847924 A US 3847924A US 00365728 A US00365728 A US 00365728A US 36572873 A US36572873 A US 36572873A US 3847924 A US3847924 A US 3847924A
Authority
US
United States
Prior art keywords
scopolammonium
compound
compounds
observed
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00365728A
Other languages
English (en)
Inventor
S Tanaka
K Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of US3847924A publication Critical patent/US3847924A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Definitions

  • scopolamine, atropine and hyoscyamine base are the essential components of the alkaloids contained in belladonna and scopolia. These compounds exhibit a strong parasympathetic blocking activity and they therefore are utilized for the purpose of therapeutical treatment of diseases such as gastric cramp, gastric ulcer, duodenal ulcer and the like. Unfortunately it was found that they show undesirable side effects such as thirst, dysuria, and palpitation and the injurious effects on central nervous system, such as illusion, hemicrania, nausea and the like.
  • Compound A N-(p-butoxybenzyl)scopolammonium bromide
  • Compound B the hitherto known butyl scopolammonium bromide
  • R and X have the same meanings as previously defined with respect to the formula given to the opening paragraph.
  • Typical solvents which have been found preferable to carry out the above reaction include lower alcohol, acetone, ether, chloroform and the like.
  • the reaction takes place readily at room temperature. In order to avoid the racemisation of the scopolamine compounds, it is advisable to carry out the reaction at a low temperature.
  • the resulting N-(p-loweralkoxybenzyl)scopolammonium bromides are easily soluble in Water.
  • the aqueous solutions thus obtained are stable to heat with no tendency of causing racemisation. The fact olfers one of the serious advantages in the production of pharmaceutical preparations.
  • R is a lower alkyl group and X is a halogen atom.
  • a compound according to claim 1 which is pmethoxybenzyl scopolarnmonium bromide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
US00365728A 1972-06-12 1973-05-31 Certain scopolammonium compounds Expired - Lifetime US3847924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47057633A JPS4919012A (US07935154-20110503-C00018.png) 1972-06-12 1972-06-12

Publications (1)

Publication Number Publication Date
US3847924A true US3847924A (en) 1974-11-12

Family

ID=13061285

Family Applications (1)

Application Number Title Priority Date Filing Date
US00365728A Expired - Lifetime US3847924A (en) 1972-06-12 1973-05-31 Certain scopolammonium compounds

Country Status (11)

Country Link
US (1) US3847924A (US07935154-20110503-C00018.png)
JP (1) JPS4919012A (US07935154-20110503-C00018.png)
AU (1) AU468339B2 (US07935154-20110503-C00018.png)
CA (1) CA1006519A (US07935154-20110503-C00018.png)
CH (1) CH572933A5 (US07935154-20110503-C00018.png)
DE (1) DE2329893A1 (US07935154-20110503-C00018.png)
FR (1) FR2187354B1 (US07935154-20110503-C00018.png)
GB (1) GB1378127A (US07935154-20110503-C00018.png)
NL (1) NL7307903A (US07935154-20110503-C00018.png)
PH (1) PH10925A (US07935154-20110503-C00018.png)
SE (1) SE403113B (US07935154-20110503-C00018.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952108A (en) * 1972-04-18 1976-04-20 Istituto De Angeli S.P.A. Scopolamine derivatives for treating ulcers and spasms
AU760009B2 (en) * 1997-10-24 2003-05-08 Newlaxant Llc Bis-quaternary ammonium derivatives as neuromuscular relaxants

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0622991Y2 (ja) * 1990-02-28 1994-06-15 沖電気工業株式会社 化合物半導体ウエハ
RU2450143C1 (ru) * 2011-03-16 2012-05-10 Открытое акционерное общество "Научно-производственное объединение "Сатурн" (ОАО "НПО "Сатурн") Газотурбинный двигатель
RU2450142C1 (ru) * 2011-03-16 2012-05-10 Открытое акционерное общество "Научно-производственное объединение "Сатурн" (ОАО "НПО "Сатурн") Газотурбинный двигатель
RU2450141C1 (ru) * 2011-03-16 2012-05-10 Открытое акционерное общество "Научно-производственное объединение "Сатурн" (ОАО "НПО "Сатурн") Газотурбинный двигатель
RU2450144C1 (ru) * 2011-03-16 2012-05-10 Открытое акционерное общество "Научно-производственное объединение "Сатурн" (ОАО "НПО "Сатурн") Газотурбинный двигатель
RU2459967C1 (ru) * 2011-04-05 2012-08-27 Открытое акционерное общество "Научно-производственное объединение "Сатурн" (ОАО "НПО "Сатурн") Двухконтурный газотурбинный двигатель

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH77A (de) * 1889-01-09 Christian Herren Wurzelschneidmaschine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952108A (en) * 1972-04-18 1976-04-20 Istituto De Angeli S.P.A. Scopolamine derivatives for treating ulcers and spasms
AU760009B2 (en) * 1997-10-24 2003-05-08 Newlaxant Llc Bis-quaternary ammonium derivatives as neuromuscular relaxants

Also Published As

Publication number Publication date
NL7307903A (US07935154-20110503-C00018.png) 1973-12-14
AU5680573A (en) 1974-12-12
FR2187354B1 (US07935154-20110503-C00018.png) 1977-09-09
DE2329893A1 (de) 1974-01-03
CA1006519A (en) 1977-03-08
JPS4919012A (US07935154-20110503-C00018.png) 1974-02-20
FR2187354A1 (US07935154-20110503-C00018.png) 1974-01-18
AU468339B2 (en) 1976-01-08
GB1378127A (en) 1974-12-18
CH572933A5 (US07935154-20110503-C00018.png) 1976-02-27
PH10925A (en) 1977-10-05
SE403113B (sv) 1978-07-31

Similar Documents

Publication Publication Date Title
RU2073677C1 (ru) Сложные эфиры тиенилкарбоновой кислоты и аминоспиртов, способ их получения и фармацевтическая композиция, обладающая антихолинергической активностью
US3847924A (en) Certain scopolammonium compounds
JPS62228016A (ja) 非−白金抗癌薬によりひき起こされる嘔吐の軽減用治療剤
JPS6016977A (ja) 芳香族化合物、その製造法およびそれを用いる医薬組成物
US4855422A (en) Process for the preparation of azoniaspironortropanol esters
US2824106A (en) Quaternary tropeine compounds and a process of making same
EP0009608B1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
US3822256A (en) Crystalline monohydrates of sodium and potassium cephalexin
US2743270A (en) Heterocyclic nitrogen compounds
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
AU704115B2 (en) Zwitterionic forms of trovafloxacin
US3696110A (en) Certain hyoscyaminium compounds
US3766188A (en) Carbonyldioxymorphinan derivatives
CA2465416A1 (en) Amine salts of an integrin receptor antagonist
US3982002A (en) Vincamine 2-ketoglutarate and compositions containing vincamine 2-ketoglutarate
US4558053A (en) Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids
US2933500A (en) Nu-aminoindolobenzoquinolizinium compounds
US3445470A (en) Heterocyclic derivatives of aryl sulfonyl carbamic acid
US3365457A (en) N [(1-, 2-, 3-indolyl)-lower alkyl]-1, 5-iminocycloalkane and-1, 5-iminocycloalkene derivatives
US2974142A (en) Morphinan derivatives
US3828048A (en) Alkylsulfonic derivatives of quinine alkaloids
JPS6145989B2 (US07935154-20110503-C00018.png)
KR810000658B1 (ko) 샌드위신의 4급 유도체의 제조방법
US2741609A (en) N-chjchjchj
KR930000113B1 (ko) 아조니아스피로노르트로판올 에스테르의 제조방법